We are live on
!
Find out more
CAG
Cypress Advisory Group Portfolio holdings
AUM
$129M
1-Year Est. Return
10.74%
This Fund
S&P 500
This Quarter
Est. Return
+6.54%
1 Year Est. Return
+10.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$6.28M
(+4.9%)
Cap. Flow
-$571K
Cap. Flow
% of AUM
-0.42%
Top 10 Holdings %
Top 10 Hldgs %
48.32%
Holding
69
New
2
Increased
15
Reduced
19
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oscar Health
OSCR
|
+$819K |
| 2 |
Otis Worldwide
OTIS
|
+$684K |
| 3 |
Check Point Software Technologies
CHKP
|
+$675K |
| 4 |
Salesforce
CRM
|
+$514K |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$392K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.4M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$600K |
| 3 |
Comfort Systems
FIX
|
+$478K |
| 4 |
Walmart Inc
WMT
|
+$249K |
| 5 |
NVO
Novo Nordisk
NVO
|
+$228K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Industrials | 20.14% |
| 3 | Consumer Discretionary | 9.75% |
| 4 | Healthcare | 9.43% |
| 5 | Financials | 9.31% |
Similar funds
BI
CPA
ECP
HHGC
MFS
TIA
BA
SRPTWM
Cypress Advisory Group's Q3 2025 Portfolio in Review
As of Q3 2025, Cypress Advisory Group held 69 positions worth $135M, up 4.9% from $129M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Cypress Advisory Group's Q3 2025 filing shows 2 new, 15 increased, 19 reduced and 2 closed positions. Its largest new stake was Oscar Health: 49,695 shares worth $941K. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $2.4M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Cypress Advisory Group's largest Q3 2025 buy was Oscar Health: 49,695 shares worth $941K.
- Cypress Advisory Group added most to Otis Worldwide in Q3 2025, an estimated $684K increase.
- Cypress Advisory Group's biggest Q3 2025 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $2.4M.
- Cypress Advisory Group fully exited Novo Nordisk in Q3 2025, selling an estimated $228K.
- Cypress Advisory Group's ten largest holdings make up 48% of its $135M portfolio in Q3 2025.
- Cypress Advisory Group opened 2 new positions and closed 2 in Q3 2025.
- Cypress Advisory Group's portfolio value rose 4.9% quarter-over-quarter to $135M.
Based on Cypress Advisory Group's 13F filing for Q3 2025, filed 29 Oct 2025.